Genmab A/S (GNMSF)
316.00
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Genmab Market Cap: 19.47B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 206.00B |
| Ascendis Pharma A/S | 12.01B |
| Evaxion AS | 41.88M |
| IO Biotech, Inc. | 60.91M |
Market Cap Related Metrics
| PE Ratio | 13.45 |
| PS Ratio | 5.544 |
| PEG Ratio | 0.1064 |
| Price to Book Value | 3.385 |
| Price to Free Cash Flow | 16.29 |
| Price | 316.00 |
| Earnings Yield | 7.44% |
| PEGY Ratio | 0.1064 |
| Operating PE Ratio | 15.05 |
| Normalized PE Ratio | 13.38 |